Oravecz T - Search Results

1

Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint.

Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, Shinton SA, Gerhardt B, Hardy RR, Oravecz T, Wiest DL. Anderson SJ, et al. Among authors: oravecz t. Immunity. 2007 Jun;26(6):759-72. doi: 10.1016/j.immuni.2007.04.012. Epub 2007 Jun 7. Immunity. 2007. PMID: 17555992 Free article.

2

The adaptor protein Sh2d3c is critical for marginal zone B cell development and function.

Al-Shami A, Wilkins C, Crisostomo J, Seshasayee D, Martin F, Xu N, Suwanichkul A, Anderson SJ, Oravecz T. Al-Shami A, et al. Among authors: oravecz t. J Immunol. 2010 Jul 1;185(1):327-34. doi: 10.4049/jimmunol.1000096. Epub 2010 May 26. J Immunol. 2010. PMID: 20505138

3

Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectors.

Stadanlick JE, Zhang Z, Lee SY, Hemann M, Biery M, Carleton MO, Zambetti GP, Anderson SJ, Oravecz T, Wiest DL. Stadanlick JE, et al. Among authors: oravecz t. J Immunol. 2011 Jul 15;187(2):664-75. doi: 10.4049/jimmunol.1100029. Epub 2011 Jun 20. J Immunol. 2011. PMID: 21690328 Free PMC article.

4

Integrin-α FG-GAP repeat-containing protein 2 is critical for normal B cell differentiation and controls disease development in a lupus model.

Al-Shami A, Crisostomo J, Wilkins C, Xu N, Humphries J, Chang WC, Anderson SJ, Oravecz T. Al-Shami A, et al. Among authors: oravecz t. J Immunol. 2013 Oct 1;191(7):3789-98. doi: 10.4049/jimmunol.1203534. Epub 2013 Aug 30. J Immunol. 2013. PMID: 23997217

5

Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development.

Al-Shami A, Jhaver KG, Vogel P, Wilkins C, Humphries J, Davis JJ, Xu N, Potter DG, Gerhardt B, Mullinax R, Shirley CR, Anderson SJ, Oravecz T. Al-Shami A, et al. Among authors: oravecz t. PLoS One. 2010 Oct 27;5(10):e13654. doi: 10.1371/journal.pone.0013654. PLoS One. 2010. PMID: 21048919 Free PMC article.

6

Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.

Rao S, Lee SY, Gutierrez A, Perrigoue J, Thapa RJ, Tu Z, Jeffers JR, Rhodes M, Anderson S, Oravecz T, Hunger SP, Timakhov RA, Zhang R, Balachandran S, Zambetti GP, Testa JR, Look AT, Wiest DL. Rao S, et al. Among authors: oravecz t. Blood. 2012 Nov 1;120(18):3764-73. doi: 10.1182/blood-2012-03-415349. Epub 2012 Sep 13. Blood. 2012. PMID: 22976955 Free PMC article.

7

Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions.

Vogel P, Donoviel MS, Read R, Hansen GM, Hazlewood J, Anderson SJ, Sun W, Swaffield J, Oravecz T. Vogel P, et al. Among authors: oravecz t. PLoS One. 2009;4(1):e4112. doi: 10.1371/journal.pone.0004112. Epub 2009 Jan 1. PLoS One. 2009. PMID: 19119317 Free PMC article.

8

5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase.

Tarver JE, Jessop TC, Carlsen M, Augeri DJ, Fu Q, Healy JP, Heim-Riether A, Xu A, Taylor JA, Shen M, Keyes PE, David Kimball S, Yu XC, Miranda M, Liu Q, Swaffield JC, Nouraldeen A, Wilson AG, Finch R, Jhaver K, Foushee AM, Anderson S, Oravecz T, Carson KG. Tarver JE, et al. Among authors: oravecz t. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6780-3. doi: 10.1016/j.bmcl.2009.09.082. Epub 2009 Sep 25. Bioorg Med Chem Lett. 2009. PMID: 19836229

9

Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors.

Jessop TC, Tarver JE, Carlsen M, Xu A, Healy JP, Heim-Riether A, Fu Q, Taylor JA, Augeri DJ, Shen M, Stouch TR, Swanson RV, Tari LW, Hunter M, Hoffman I, Keyes PE, Yu XC, Miranda M, Liu Q, Swaffield JC, David Kimball S, Nouraldeen A, Wilson AG, Foushee AM, Jhaver K, Finch R, Anderson S, Oravecz T, Carson KG. Jessop TC, et al. Among authors: oravecz t. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6784-7. doi: 10.1016/j.bmcl.2009.09.081. Epub 2009 Sep 25. Bioorg Med Chem Lett. 2009. PMID: 19836232

10

Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.

Oda SK, Strauch P, Fujiwara Y, Al-Shami A, Oravecz T, Tigyi G, Pelanda R, Torres RM. Oda SK, et al. Among authors: oravecz t. Cancer Immunol Res. 2013 Oct;1(4):245-55. doi: 10.1158/2326-6066.CIR-13-0043-T. Cancer Immunol Res. 2013. PMID: 24455753 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters